AN OPEN-LABEL, MECHANISTIC STUDY TO EXAMINE THE EFFECT OF EMPAGLIFLOZIN (25 MG Q.D.) ON KINETICS OF RENAL GLUCOSE REABSORPTION, INSULIN SECRETION, AND INSULIN SENSITIVITY IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND HEALTHY CONTROLS